Previous 10 | Next 10 |
DBV Technologies (DBVT -41.1%) ADRs have lost sharply after the company announced its plans to begin a new Phase 3 pivotal trial for the modified Viaskin Peanut patch. The study for the intended patient population will be designed to evaluate the modified Viaskin Peanut (mVP) patch, which is ...
Gainers: uCloudlink Group (NASDAQ:UCL) +15%. Quantum-Si Incorporated QSI +10%. Micron Technology MU +7%. Braze BRZE +6%. JAKKS Pacific (NASDAQ:JAKK) +6%. Losers: CytomX Therapeutics CTMX -29%. DBV Technologies (NASDAQ:DBVT) -13%. Sigilon Therape...
Montrouge, France, December 20, 2021 DBV Technologies Provides Update on Investigational Viaskin ™ Peanu t DBV Technologies S.A. (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, tod...
Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2021 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris...
Montrouge, France, November 24, 2021 DBV Technologies to Participate in an Upcoming Investor Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced its participation ...
Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2021 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris IS...
Shares of DBV Technologies (NASDAQ: DBVT) were jumping 8.9% as of 12:06 p.m. EDT on Monday after rising as much as 11.9% earlier in the day. The solid gain followed the company's announcement that it will present new clinical study results for experimental peanut allergy drug Viaski...
ABVC BioPharma ABVC +233% amid social media buzz Golden Star Resources GSS +18% Chifeng Jilong Gold to buy Golden Star Resources in $470M deal ANI Pharmaceuticals ANIP +15% on Q3 earnings. Archer Aviation (NYSE:ACHR) +11%. DBV Technologies (NASDAQ:DBVT) +13% to h...
Montrouge, France, November 1, 2021 DBV Technologies to Highlight New Long-term Data from REALISE Trial at ACAAI 2021 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical compa...
BEST BEST +22% offloads its express business in China to J&T Express in a deal value of RMB6.8B WiMi Hologram Cloud (NASDAQ:WIMI) +20% submitted the trademark application of "WIMI METAVERSE" to lay out the rapidly developing Metaverse industry IonQ (NYSE:IONQ) +15%. Exela T...
News, Short Squeeze, Breakout and More Instantly...
DBV Technologies S.A. Company Name:
DBVT Stock Symbol:
NASDAQ Market:
DBV Technologies S.A. Website:
Châtillon, France, July 30, 2024 DBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for Accessing or Consulting the Report DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutic...
Châtillon, France, July 30, 2024 DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results VITESSE enrollment in peanut allergic 4-7-year-olds is on-track and recruitment is expecte...
Châtillon, France, July 29, 2024 DBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, toda...